# Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation

> **NCT05340712** · NA · UNKNOWN · sponsor: **United Pharmaceuticals** · enrollment: 80 (estimated)

## Conditions studied

- Functional Constipation

## Interventions

- **DIETARY_SUPPLEMENT:** new infant formula
- **DIETARY_SUPPLEMENT:** Standard formula

## Key facts

- **NCT ID:** NCT05340712
- **Lead sponsor:** United Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-20
- **Primary completion:** 2023-12
- **Final completion:** 2024-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05340712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05340712, "Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05340712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*